NM_000944.5:c.1538A>G

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_000944.5(PPP3CA):​c.1538A>G​(p.Asn513Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000182 in 1,591,828 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. N513N) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000019 ( 0 hom. )

Consequence

PPP3CA
NM_000944.5 missense

Scores

4
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 4.57

Publications

0 publications found
Variant links:
Genes affected
PPP3CA (HGNC:9314): (protein phosphatase 3 catalytic subunit alpha) Enables several functions, including ATPase binding activity; calmodulin binding activity; and calmodulin-dependent protein phosphatase activity. Involved in several processes, including calcineurin-NFAT signaling cascade; peptidyl-serine dephosphorylation; and response to calcium ion. Located in several cellular components, including cytosol; dendritic spine; and nucleoplasm. Part of calcineurin complex. Colocalizes with cytoplasmic side of plasma membrane. Implicated in developmental and epileptic encephalopathy 91. Biomarker of focal segmental glomerulosclerosis and schizophrenia. [provided by Alliance of Genome Resources, Apr 2022]
PPP3CA Gene-Disease associations (from GenCC):
  • arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • developmental and epileptic encephalopathy 91
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.11734682).
BP6
Variant 4-101025893-T-C is Benign according to our data. Variant chr4-101025893-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 1474325.
BS2
High AC in GnomAdExome4 at 27 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000944.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPP3CA
NM_000944.5
MANE Select
c.1538A>Gp.Asn513Ser
missense
Exon 14 of 14NP_000935.1Q08209-1
PPP3CA
NM_001130691.2
c.1508A>Gp.Asn503Ser
missense
Exon 13 of 13NP_001124163.1Q08209-2
PPP3CA
NM_001130692.2
c.1382A>Gp.Asn461Ser
missense
Exon 12 of 12NP_001124164.1Q08209-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPP3CA
ENST00000394854.8
TSL:1 MANE Select
c.1538A>Gp.Asn513Ser
missense
Exon 14 of 14ENSP00000378323.3Q08209-1
PPP3CA
ENST00000394853.8
TSL:1
c.1508A>Gp.Asn503Ser
missense
Exon 13 of 13ENSP00000378322.4Q08209-2
PPP3CA
ENST00000323055.10
TSL:1
c.1382A>Gp.Asn461Ser
missense
Exon 12 of 12ENSP00000320580.6Q08209-3

Frequencies

GnomAD3 genomes
AF:
0.0000134
AC:
2
AN:
149808
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000296
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000327
AC:
8
AN:
244530
AF XY:
0.0000302
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000725
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000187
AC:
27
AN:
1442020
Hom.:
0
Cov.:
35
AF XY:
0.0000223
AC XY:
16
AN XY:
717126
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32730
American (AMR)
AF:
0.00
AC:
0
AN:
42870
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25318
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37996
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84914
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52716
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5664
European-Non Finnish (NFE)
AF:
0.0000227
AC:
25
AN:
1100650
Other (OTH)
AF:
0.0000338
AC:
2
AN:
59162
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000134
AC:
2
AN:
149808
Hom.:
0
Cov.:
30
AF XY:
0.0000137
AC XY:
1
AN XY:
72988
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
40690
American (AMR)
AF:
0.00
AC:
0
AN:
15008
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3454
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5022
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4666
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10134
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
310
European-Non Finnish (NFE)
AF:
0.0000296
AC:
2
AN:
67562
Other (OTH)
AF:
0.00
AC:
0
AN:
2050
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.0385499), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000675
Hom.:
0
ExAC
AF:
0.0000330
AC:
4
EpiCase
AF:
0.0000547
EpiControl
AF:
0.00

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Developmental and epileptic encephalopathy 91;C4748872:Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development (1)
-
-
1
Inborn genetic diseases (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.059
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.55
CADD
Uncertain
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.18
T
Eigen
Benign
-0.13
Eigen_PC
Benign
0.12
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.96
D
M_CAP
Benign
0.0089
T
MetaRNN
Benign
0.12
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.90
L
PhyloP100
4.6
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-0.66
N
REVEL
Benign
0.045
Sift
Uncertain
0.012
D
Sift4G
Benign
0.24
T
Polyphen
0.0090
B
Vest4
0.25
MutPred
0.13
Gain of glycosylation at N513 (P = 0.0075)
MVP
0.53
MPC
0.87
ClinPred
0.12
T
GERP RS
6.0
Varity_R
0.098
gMVP
0.43
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199874915; hg19: chr4-101947050; API